Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of Combined use of Fecal Multigene Mutation Test and Fecal Immunochemical Test for Colorectal Cancer Screening.

Clinical laboratory - 1 Dec 2022

Chen Juan, Lin Jie, Zhang Lijing, Chen Mengshi, Yu Xunbin, Wu Yijuan, Wang Tao, Xu Rongrong, Tian Tian, Sun Aijuan, Zhang Tiantian, Lu Yan, Ba Zhaofen, Cheng Xiaowei, Chen Minghong

Abstract excerpt

BACKGROUND: The aim was to investigate the value of concomitant use of fecal KRAS-APC-p53-BRAF mutation test and a fecal immunochemical test (FIT) for colorectal cancer (CRC) screening. METHODS: Stool samples of 279 subjects were collected from the Fujian provincial hospital and divided into five groups: CRC (n = 82); advanced adenoma (AA, n = 76); non-advanced adenoma (NAA, n = 24); healthy control (n = 85); and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenoma
Share to Colonoscopy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to Early Detection of Cancer

Share to Mass Screening

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins p21(ras)

Source

Identifiers

PMID: 36546736
DOI: 10.7754/Clin.Lab.2022.211202

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of Combined use of Fecal Multigene Mutation Test and Fecal Immunochemical Test for Colorectal Cancer Screening.PMID 36546736Read ↗

Plausibility of an extensive use of stool DNA test for screening advanced colorectal neoplasia.Semantic proximity Read ↗

Evaluation of combined detection of multigene mutation and SDC2/SFRP2 methylation in stool specimens for colorectal cancer early diagnosis.Semantic proximity Read ↗

Diagnostic accuracy of the faecal immunochemical test highest in the 40–49 age groupSemantic proximity Read ↗

Multitarget stool DNA testing for colorectal-cancer screening.Semantic proximity Read ↗

Fecal Multidimensional Assay for Non-Invasive Detection of Colorectal Cancer: Fecal Immunochemical Test, Stool DNA Mutation, Methylation, and Intestinal Bacteria AnalysisSemantic proximity Read ↗

Evaluating the Clinical Performance of a Dual-Target Stool DNA Test for Colorectal Cancer DetectionSemantic proximity Read ↗

Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.Semantic proximity Read ↗

A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal Neoplasms.Semantic proximity Read ↗

Fecal immunochemical test accuracy in familial risk colorectal cancer screening.Semantic proximity Read ↗

The Role of Fecal Fusobacterium nucleatum and pks+ Escherichia coli as Early Diagnostic Markers of Colorectal CancerSemantic proximity Read ↗

Diagnostic accuracy of Faecal Immunochemical Testing for patients with symptoms of colorectal cancer: a retrospective cohort study of 14,487 consecutive test requests from English primary careSemantic proximity Read ↗

Diagnostic value of stool DNA testing for multiple markers of colorectal cancer and advanced adenoma: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.